HIV Infections: all 4,340 studies

Page 40 of 44. Open to participants first (240), then studies with results posted, then the rest; newest registration first within each.

• A Phase IIIB Open-Label, Comparative Study to Evaluate Saquinavir Soft Gel Capsule (SGC) Treatment in Combination With Other Antiretrovirals in HIV-1 Infected Antiretroviral-Naive PatientsCompletedNCT00002178Phase 3
• A Pilot Open Label Trial of HIV Therapy With d4T (Stavudine), ddI (Didanosine), Nelfinavir and Hydroxyurea in Subjects With Recent HIV InfectionCompletedNCT00002177Not applicable
• A Pilot Open Label Trial of HIV Therapy With d4T (Stavudine), ddI (Didanosine), Nelfinavir and Hydroxyurea in Subjects With Early Asymptomatic HIV InfectionCompletedNCT00002176Not applicable
• Epicutaneous 1-Chloro-2, 4-Dinitrobenzene (DNCB) Patch in HIV Infection.CompletedNCT00002175Phase 1
• Further Evaluation of Thalidomide's Ability to Potentiate the Immune Response to HIV-Infected PatientsCompletedNCT00002174Not applicable
• An Expanded Access Open Label Protocol of Remune (HIV-1 Immunogen) in HIV-1-Infected Adults With CD4 Count 550 Cells /Ml and Greater.CompletedNCT00002173Not applicable
• An Expanded Access Open-Label, Compassionate Use Protocol of Remune in HIV-1-Infected Adults With CD4 Count Less Than 300 Cells/MlCompletedNCT00002172Not applicable
• A Study of Viracept in HIV-Positive WomenCompletedNCT00002171Phase 2
• A Comparison of Two Anti-HIV Triple-Drug Combinations in HIV-Infected PatientsCompletedNCT00002168Not applicable
• An Open-Label, Non-Randomized Trial to Evaluate the Tolerability and Safety of Viramune (Nevirapine) in Adult and Pediatric Patients With Progressive HIV DiseaseCompletedNCT00002166Phase 3
• Viracept Expanded Access ProgramCompletedNCT00002165Not applicable
• Phase I Study of Safety, Tolerability, and Pharmacokinetics of Viracept in HIV-1 Infected Children and Exposed InfantsCompletedNCT00002164Phase 1
• A Randomized, Parallel Arm, Comparative, Open Label, Multicenter Study of the Activity and Safety of Two Formulations of Saquinavir in Combination With Other Antiretroviral DrugsCompletedNCT00002162Phase 2
• A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Adefovir Dipivoxil When Added to Standard Antiretroviral Therapy for the Treatment of HIV-Infected Patients With CD4 Cell Counts >= 200/mm3CompletedNCT00002161Not applicable
• A Six-Month Safety and Antiviral Study in HIV-1 Seropositive, AZT-Experienced Patients With CD4 Counts Less Than or Equal to 50 Cells/mm3 to Evaluate MK-639 Alone Versus Zidovudine (AZT) and 3TC Versus the Combination of MK-639 With AZT/3TCCompletedNCT00002155Not applicable
• A Study of WF 10 IV Solution in Patients With Advanced HIV DiseaseCompletedNCT00002152Phase 2
• A Randomized, Double-Blind Active-Controlled, Dose-Ranging Study of the Safety and Efficacy of Chronically Administered MDL 28,574A in the Treatment of HIV-Infected PatientsCompletedNCT00002151Phase 2
• A Study of the Safety and Efficacy of Chronically Administered MDL 28,574A in the Treatment of HIV-Infected PatientsCompletedNCT00002150Phase 2
• A Phase I Trial to Evaluate the Safety and Pharmacokinetics of 1592U89CompletedNCT00002141Phase 1
• A Long-Term, Follow-On Safety Study of Four Doses of OPC-8212 (Vesnarinone) in HIV-Infected PersonsCompletedNCT00002130Not applicable
• A Phase I Study of Three Doses of OPC-8212 (Vesnarinone) in HIV-Infected Persons With CD4+ Cell Number > 300 Cells/mm3CompletedNCT00002129Phase 1
• Phase I Study of the Safety, Tolerance, and Pharmacokinetics of 9-[2-(Bispivaloyloxymethyl)Phosphonylmethoxyethyl]Adenine (Bis-POM PMEA; Adefovir Dipivoxil) in HIV-Infected PatientsCompletedNCT00002128Phase 1
• A Randomized, Controlled, Multicenter Trial of Filgrastim (Recombinant-Methionyl Human Granulocyte Colony Stimulating Factor; G-CSF) for the Prevention of Grade 4 Neutropenia in Patients With HIV Infection.CompletedNCT00002126Phase 2
• A Double-Blind, Randomized, Dose Response Study of Three Doses of Delavirdine Mesylate (U-90152S) in Combination With Zidovudine (ZDV) Versus ZDV Alone in HIV-1 Infected Individuals With CD4 Counts of 200-500mm3CompletedNCT00002124Phase 3
• A Double-Blind, Randomized, Comparative Study of Delavirdine Mesylate (U-90152S) in Combination With Didanosine (ddI) Versus ddI Alone in HIV-1 Infected Individuals With CD4 Counts of <= 300/mm3CompletedNCT00002123Phase 3
• A Phase I/II Clinical Study of WF 10 IV Solution ( TCDO ) in Patients With HIV InfectionCompletedNCT00002119Phase 1
• An Open-Label Safety Program for the Use of Zalcitabine (Dideoxycytidine; ddC) in Pediatric Patients With Symptomatic HIV Infection Who Have Failed or Are Intolerant to AZT Monotherapy, or Who Have Completed Other ddC Protocols, or Are Ineligible for Other Ongoing Clinical StudiesCompletedNCT00002118Not applicable
• A Randomized, Open-Label Study of Alternative Treatment Combinations of Dideoxycytidine (HIVID; ddC) and Zidovudine (AZT) in Patients With HIV InfectionCompletedNCT00002117Phase 3
• A Phase I/II Study of the Safety, Tolerance, and Pharmacokinetics of 9-(2-Phosphonylmethoxyethyl)Adenine ( PMEA; Adefovir ) in Patients With Advanced HIV Disease.CompletedNCT00002115Phase 1
• A Double-Blind, Randomized Parallel Group Study Comparing Procysteine to Placebo in HIV-Infected Patients Who Are Taking Antiretroviral NucleosidesCompletedNCT00002114Phase 2
• Comparative Randomized Study of the Efficacy, Safety, and Toleration of Fluconazole Oral Suspension or Nystatin Oral Suspension in the Treatment of Patients With Oropharyngeal Candidiasis in Association With the Acquired Immunodeficiency SyndromeCompletedNCT00002112Not applicable
• A Dose-Escalating Study of Ro 31-8959 ( HIV Protease Inhibitor ) in Patients With HIV Disease.CompletedNCT00002111Phase 1
• A Phase II/III Study of Cysteamine (Mercaptoethylamine) and Zidovudine for the Treatment of HIV DiseaseCompletedNCT00002110Phase 2
• Double-Blind Study of Timunox (Thymopentin) in Asymptomatic HIV-Infected Patients Receiving Either Mono (AZT or ddI) or Combination (AZT / ddI or AZT / ddC) Anti-Retroviral TherapyCompletedNCT00002109Phase 3
• 3TC (Lamivudine; GR109714X) Open-Label ProgramCompletedNCT00002108Not applicable
• A Phase I Study of Subcutaneously Administered Proleukin (Aldesleukin) in HIV-Infected PatientsCompletedNCT00002107Phase 1
• A Pilot Randomized, Double-Blind, Placebo-Controlled, Parallel Design, Multicenter Trial to Evaluate the Effect of Ranitidine on Immunologic Indicators in Asymptomatic HIV-1 Infected Subjects With a CD4 Cell Count Between 400-700 Cells/mm3CompletedNCT00002106Phase 2
• Phase I/II Study of Curdlan SulfateCompletedNCT00002100Phase 1
• Phase II/III Study of the Tolerance and Efficacy of Combined Use of Didanosine (2',3'-Dideoxyinosine; ddI) and Lentinan in HIV-Positive PatientsStatus unknownNCT00002099Phase 2
• Phase I/II Study of the Tolerance and Efficacy of Combined Use of Didanosine (2',3'-Dideoxyinosine; ddI) and Lentinan in HIV-Positive PatientsCompletedNCT00002098Phase 1
• A Phase I/II Clinical Study of Nystatin I.V. (Intravenous) in Patients With HIV Infection.CompletedNCT00002097Phase 1
• A Randomized, Double-Blind Study of the Efficacy and Safety of Oral Ganciclovir for the Prevention of CMV Disease in People Infected With the Human Immunodeficiency VirusCompletedNCT00002095Not applicable
• Prospective Open-Label Study of the Emergence of Drug Resistance in Patients Infected With HIV-1 Who Are Taking Oral U-87201ECompletedNCT00002094Not applicable
• A Study to Evaluate the Effect of Cimetidine on CD4 Lymphocyte Counts in HIV InfectionCompletedNCT00002092Not applicable
• An Evaluation of Pentoxifylline in HIV-Positive Persons With Symptomatic HIV Infection and a Karnofsky Score > 40 Percent and < 100 PercentCompletedNCT00002091Not applicable
• An Open, Multicenter, Randomized, Dose-Ranging Study of Azithromycin in the Treatment of Disseminated Mycobacterium Avium-Intracellulare Complex Infection (MAC) in Patients With Acquired Immune Deficiency Syndrome (AIDS)CompletedNCT00002090Not applicable
• Treatment of Patients With Human Immunodeficiency Virus (HIV)-Related Chronic Diarrhea With Saccharomyces Boulardii or Placebo: A Double Blind TrialCompletedNCT00002088Phase 2
• Safety, Tolerance, Efficacy and Pharmacokinetics of Multiple Doses of sCD4-PE40 in the Treatment of HIV-Infected IndividualsCompletedNCT00002087Phase 1
• A Randomized Trial to Evaluate the Safety and Efficacy of Combination Therapy With Retrovir ( AZT ) and HIVID ( ddC ) Versus Retrovir, HIVID, and Wellferon ( Interferon Alfa-n1 ) for the Treatment of HIV InfectionCompletedNCT00002086Phase 2
• Azithromycin in the Treatment of Cryptosporidiosis in Patients With Acquired Immune Deficiency Syndrome (AIDS): A Randomized, Multi-Center, Placebo-Controlled, Double-Blind StudyCompletedNCT00002082Not applicable
• Open-Label Program of Dideoxycytidine ( ddC ) to Be Used in Combination With Zidovudine ( AZT ) for Treatment of Advanced HIV DiseaseCompletedNCT00002081Not applicable
• Phase II Study of the Safety and Surrogate Marker Efficacy of Butyldeoxynojirimycin (SC-48334) and AZT in Symptomatic HIV-1 Infected Patients With 200 - 500 CD4+ Cells/mm3. (NOTE: Asymptomatic HIV-1 Infected Patients Also Eligible)CompletedNCT00002079Phase 2
• Phase I Study of Alferon N Injection in Persons With Asymptomatic Human Immunodeficiency Virus (HIV) InfectionCompletedNCT00002078Phase 1
• Multicenter Comparison of Fluconazole (UK-49,858) and Amphotericin B as Maintenance Treatment for the Prevention of Relapse of Cryptococcal Meningitis in Patients With Acquired Immunodeficiency SyndromeCompletedNCT00002074Not applicable
• Depot Disulfiram for AIDS and ARCCompletedNCT00002065Not applicable
• A Double-Blind Placebo Controlled Study To Determine the Optimal Immunopharmacological Dose Level of Isoprinosine in Immunodepressed VolunteersCompletedNCT00002059Not applicable
• A Study of Thymopentin Effects on HIV-1 Infectivity of Blood Mononuclear Cells and Semen in HIV Infected PatientsCompletedNCT00002050Not applicable
• Double Blind Study of Thymopentin Effects on HIV-1 Infectivity of Blood Mononuclear Cells and Semen in HIV Infected PatientsCompletedNCT00002049Not applicable
• A Dose-Frequency Trial of Oral Retrovir in Patients With AIDS or Severe ARCCompletedNCT00002046Not applicable
• A Prospective Double-Blind Study of Retrovir in Early HIV InfectionCompletedNCT00002045Not applicable
• A Pilot Study To Evaluate the Effect of Retrovir (Zidovudine: AZT) in the Treatment of Human Immunodeficiency Virus (HIV) Associated Dementia and Neuromuscular DiseasesCompletedNCT00002044Not applicable
• Phase I Safety Study of Anti-HIV Immune Serum Globulin (Human)CompletedNCT00002036Phase 1
• A Third-Party Blinded, Placebo Controlled Comparative Study of AS-101 Administered Intravenously in HIV Positive Patients With Advanced DiseaseCompletedNCT00002033Not applicable
• Evaluation of the Epidermal Langerhans Cell Population in AIDS / ARC Patients by the Topical Application of a Potent Contact Allergen (1-Chloro-2,4-Dinitro-Chlorobenzene) (DNCB)CompletedNCT00002031Not applicable
• Long-Term Nutritional Support in Patients With the Acquired Immunodeficiency Syndrome: Comparison of Liposyn III 2 Percent With Liposyn II 20 PercentCompletedNCT00002029Not applicable
• A Treatment IND (Investigational New Drug) Protocol for the Use of Videx (2',3'-Dideoxyinosine, ddI) in Patients With Acquired Immunodeficiency Syndrome (AIDS) or AIDS- Related Complex (ARC) Who Are Intolerant to Zidovudine (Retrovir)CompletedNCT00002028Not applicable
• An Oral Dose-Ranging Finding Study in Patients With HIV Disease, CDC Classification Groups IIB, III, and IV-C2CompletedNCT00002023Not applicable
• An Open Study of Foscarnet Treatment of Acyclovir-Resistant Herpes Simplex Virus in Patients With the Acquired Immunodeficiency Syndrome and Other ImmunodeficienciesCompletedNCT00002021Not applicable
• Trial of an Alternative Dosing Regimen of Oral Retrovir in Patients With AIDS or Advanced ARCCompletedNCT00002020Not applicable
• Safety and Efficacy of Amphotericin B Lipid Complex in the Treatment of Cryptococcal Meningitis in Patients With the Acquired Immunodeficiency SyndromeCompletedNCT00002019Not applicable
• Double-Blind, Randomized, Dose Ranging Study of Alferon LDO (Low Dose Oral Interferon Alfa-n3 (Human Leukocyte Derived)) in HIV+ SubjectsCompletedNCT00002018Not applicable
• Immunomodulation of HIV-1 Infected Individuals With PEG-Interleukin-2CompletedNCT00002017Not applicable
• A Phase I/II Trial to Assess the Safety and Tolerance of Escalating Doses of a Human Anti-Cytomegalovirus Monoclonal Antibody (SDZ MSL-109) in Patients With the Acquired Immunodeficiency Syndrome and CMV RetinitisCompletedNCT00002016Phase 1
• A Phase I Study to Evaluate the Pharmacokinetics, Safety and Antiviral Effects of Concurrent Administration of Zidovudine (AZT) and 2'3'-Dideoxyinosine (ddI) in Patients With Human Immunodeficiency Virus (HIV)CompletedNCT00002014Phase 1
• A Safety, Pilot Pharmacokinetics and Neurocognitive Study of AS-101 in Combination With Zidovudine in AIDS/ARC PatientsCompletedNCT00002013Not applicable
• Double-Blind, Randomized, Placebo-Controlled Study of Low Dose Oral Interferon Alfa-n3 (Human Leukocyte Derived) in ARC PatientsCompletedNCT00002012Not applicable
• A Pilot Trial Evaluating an Alternating Schedule of Recombinant Human GM-CSF and Azidothymidine in Patients With HIV Infection and LeukopeniaCompletedNCT00002007Not applicable
• A Phase I/II Pilot Study of Simultaneously Administered Rhu GM-CSF ( CHO Cell ) and Azidothymidine ( AZT ) in Patients With Severe HIV Infection and Leukopenia: Pharmacokinetics and FeasibilityCompletedNCT00002006Phase 1
• A Randomized, Double-Blind, Placebo Controlled Study of l-Leucovorin in Combination With Trimethoprim / Sulfamethoxazole in the Therapy of Pneumocystis Carinii Pneumonia in Patients With the Acquired Immunodeficiency SyndromeCompletedNCT00002002Not applicable
• The Antiviral Efficacy of Concurrent Zidovudine and 2',3'-Dideoxyinosine or 2',3'-Dideoxycytidine in Patients With Human Immunodeficiency Virus DiseaseCompletedNCT00002001Not applicable
• Pharmacokinetics of Nystatin LF I.V. in Patients With Acquired Immune Deficiency Syndrome-Related Complex (ARC)CompletedNCT00001998Not applicable
• Safety and Efficacy of Polyethylene Glycolated IL-2 (PEG IL-2) Plus Zidovudine or Dideoxyinosine in HIV Positive, Asymptomatic and Symptomatic IndividualsCompletedNCT00001997Not applicable
• A Pilot Study of 566C80 for the Salvage Treatment of Toxoplasmic Encephalitis in Patients Infected With the Human Immunodeficiency Virus (HIV) Who Have Failed or Are Intolerant of Pyrimethamine-SulfadiazineCompletedNCT00001994Not applicable
• Initial Phase II Efficacy and Safety Study of SC-48334 Administered in Combination With Low-Dose Zidovudine (AZT) to Symptomatic HIV-1 Infected Patients With = or > 200 to = or < 500 CD4+ Cells/mm3CompletedNCT00001993Phase 2
• A Phase I Study of the Safety and Immunogenicity of Rgp 120/HIV-1IIIB Vaccine in HIV-1 Seropositive Adult VolunteersCompletedNCT00001992Phase 1
• A Randomized Phase II Efficacy, Activity and Safety Study of GLQ223 Alone and in Combination With Zidovudine in Symptomatic HIV-Infected Patients Without Prior Treatment With GLQ223 or TrichosanthinCompletedNCT00001989Phase 2
• Once-Daily Drug Regimen for HIV-Infected PatientsCompletedNCT00001968Phase 1
• Intermittent Versus Continuous Medication in the Treatment of HIVCompletedNCT00001967Phase 4
• A Study of Health-Related Quality of Life in HIV-Infected Patients Undergoing Structured Treatment Interruptions of Highly Active Antiretroviral TherapyCompletedNCT00001948
• Immune and Viral Status of HIV-Infected Patients After Stopping Combination Antiretroviral TherapyCompletedNCT00001899
• Observation of HIV-Infected Children Receiving Protease Inhibitor and Reverse Transcriptase InhibitorCompletedNCT00001826
• Combination Drug Treatment of Pediatric HIV InfectionCompletedNCT00001818Phase 1
• Drug Interactions Among Anti-HIV AgentsCompletedNCT00001766Phase 1
• Subcutaneously Administered Interleukin-12 Therapy in HIV-Infected Patients With Disseminated Mycobacterium Avium Complex InfectionCompletedNCT00001763Phase 1
• Magnetic Resonance Imaging of the Face and BonesCompletedNCT00001762
• Continued Antiretroviral Therapy With Abacavir, Amprenavir and EfavirenzCompletedNCT00001758Phase 2
• Influences on HIV Infected Subjects' Willingness to Participate in Research and Ability to Give Informed ConsentCompletedNCT00001717
• A Pilot Study of Adherence to Oral Medication and Health Beliefs of Adolescents With HIV and Their MothersCompletedNCT00001699
• A Pilot Study of the Immunologic Reconstitution in HIV-1 Infected Children Receiving Highly Active Antiretroviral Therapy With Combination Ritonavir, Nevirapine and StavudineCompletedNCT00001688Phase 2
• A Pilot Study of the Patterns of Cellular Gene Expression in HIV-1 Patients Following Clinical Events Which Increase Plasma Virus ConcentrationsCompletedNCT00001681

← HIV Infections overview